Gain Therapeutics Presents New Preclinical Data from its Gaucher Disease Program at the 19th Annual WORLDSymposium

Author's Avatar
Feb 27, 2023

Study results support the disease-modifying potential of GCase-targeting small molecule therapy for neuronopathic Gaucher disease